Table 5.
Bivariate Results: Current HIV Medication-Taking Characteristics That Are Statistically Significantly Correlated (p < .05) with Preferred Choice of HIV Control Strategy (United States, 2018)
| |
Preferred choice of strategy to control HIV (mutually exclusive) |
||||
|---|---|---|---|---|---|
| Characteristic | Prefer current, daily pill version of HIV medication over all other options | Prefer long-acting injectable or implantable form of HIV medication that lasts for 1 month over all other options | Prefer long-acting injectable or implantable form of HIV medication that lasts for 2 months over all other options | Prefer long-acting injectable or implantable form of HIV medication that lasts for 6 months over all other options | Prefer new HIV remission strategy over all other options |
| Frequency of taking ART pills or tablets | Taking pills twice or more daily (OR = 3.95) more likely to prefer switching to this strategy than those taking pills only once | Taking pills twice or more daily (OR = 3.57) more likely to prefer switching to this strategy than those taking pills only once | |||
| Attitude toward current ART medication | People feeling grateful for ART medication for keeping them healthy (OR = 0.45) less likely to prefer switching to this strategy than those not feeling the same way about ART medication | ||||
| Remembering to take current ART medication | People having trouble remembering to take ART medication on time (OR = 3.97) more likely to prefer staying with current HIV medication than those not having trouble remembering to take medication on time | ||||
| Willingness to try HIV remission to avoid long-term consequences of HIV treatment | People willing to try HIV remission strategy (OR = 0.03) less likely to prefer staying with current HIV medication than those not | ||||
Number of ART pills or tablets taken per day, whether timing of ART is affected by food or other drugs, presence of side effects of current ART, self-assessed attitude toward trying an alternative HIV therapy, and previous volunteering for HIV treatment or HIV cure studies are not statistically significantly correlated with preferred choice of HIV control strategy.